Integral Diagnostics Limited
Integral Diagnostics Limited
- P/E ratio
- 27.64
Your view on IDX.AX
Overview
What the company does, where it operates, and who runs it.
About Integral Diagnostics Limited
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Ian Kadish
- Headquarters
- 45 William Street, Melbourne, VIC, AU
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Ian Kadish
- Headquarters
- 45 William Street, Melbourne, VIC, AU
Integral Diagnostics Limited operates within the healthcare sector, providing essential diagnostic imaging services. These services are delivered to general practitioners, medical specialists, allied health professionals, and their patients across Australia and New Zealand.
The company manages its service delivery through a network of 67 radiology clinics. Integral Diagnostics was incorporated in 2008 and maintains its primary corporate office in Melbourne, Australia.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Integral Diagnostics Limited from FRC's valuation model, read against the market price. IDX.AX last traded at AUD 2.18, 27.6× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Integral Diagnostics Limited. Starting points for Integral Diagnostics Limited: P/E 27.6, EPS AUD 0.06, beta 0.14 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Integral Diagnostics Limited. Integral Diagnostics Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Integral Diagnostics Limited. Trailing twelve-month EPS for Integral Diagnostics Limited stands at AUD 0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.00 | AUD 0.06 | AUD 0.11 | AUD 0.13 |
| Lowest estimate | AUD 0.00 | AUD 0.06 | AUD 0.10 | AUD 0.11 |
| Highest estimate | AUD 0.00 | AUD 0.06 | AUD 0.14 | AUD 0.18 |
| Number of analysts | 0 | 1 | 10 | 10 |
| A year ago | AUD 0.031 | AUD 0.05 | AUD 0.061 | — |
| Growth vs a year ago | — | +24.0% | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 380.65M | AUD 396.74M | AUD 824.88M | AUD 870.64M |
| Lowest estimate | AUD 380.65M | AUD 396.74M | AUD 821.31M | AUD 858.70M |
| Highest estimate | AUD 380.65M | AUD 396.74M | AUD 833.91M | AUD 882.33M |
| Number of analysts | 10 | 1 | 12 | 12 |
| A year ago | AUD 215.70M | AUD 238.44M | AUD 788.62M | — |
| Growth vs a year ago | +76.5% | +66.4% | +4.6% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Integral Diagnostics Limited. Integral Diagnostics Limited has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ACL.AXAustralian Clinical Labs Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| HLS.AXHealius Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| SHL.AXSonic Healthcare Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| SKHHYSonic Healthcare Limited | Healthcare | OTC | $8.2B | ||
| SLDXStella Diagnostics Inc. | Healthcare | OTC | $1.4M | ||
| SPDESpeedus Corp. | Healthcare | OTC | $416 | ||
| SZLSFStageZero Life Sciences Ltd. | Healthcare | OTC | $61,766 | ||
| TDSGFTelo Genomics Corp. | Healthcare | OTC | $3.8M | ||
| TELO.VTelo Genomics Corp. | Healthcare | TSXV | $4.0M | ||
| THOXFBioPorto A/S | Healthcare | OTC | $73.8M | ||
| TMOThermo Fisher Scientific Inc. | Healthcare | NYSE | $256.7B | ||
| TMO.NEThermo Fisher Scientific Inc. | Healthcare | NEO | — | ||
| TOMDFTodos Medical Ltd. | Healthcare | OTC | $14,081 | ||
| TTOOT2 Biosystems, Inc. | Healthcare | OTC | $11,218 | ||
| TWSTTwist Bioscience Corporation | Healthcare | NASDAQ | $7.7B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VXUSVanguard Total International Stock ETF | $163.2B in assets | 0.00% | |
| VEAVanguard FTSE Developed Markets ETF | $231.6B in assets | 0.00% | |
| DISVDimensional - International Small Cap Value ETF | $5.1B in assets | 0.03% | |
| VSSVanguard FTSE All-World ex-US Small-Cap ETF | $11.6B in assets | 0.01% | |
| DDLSWisdomTree Dynamic International SmallCap Equity ETF | $410M in assets | 0.04% | |
| DLSWisdomTree International SmallCap Dividend Fund | $1.0B in assets | 0.03% | |
| DTHWisdomTree International High Dividend Fund | $635M in assets | 0.02% | |
| GWXState Street SPDR S&P International Small Cap ETF | $882M in assets | 0.01% | |
Largest holders first, then the funds most concentrated in IDX.AX.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Integral Diagnostics Limited. Coverage tracks Integral Diagnostics Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Integral Diagnostics Limited.